Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Sep 11:4:1477350.
doi: 10.3389/fneph.2024.1477350. eCollection 2024.

Editorial: IgA nephropathy: a nephrologist's challenge in 2023

Fausta Catapano  1 , Oliver Flossmann  2 , Lucia Del Vecchio  3
Affiliations
Editorial

Editorial: IgA nephropathy: a nephrologist's challenge in 2023

Fausta Catapano et al. Front Nephrol. .
No abstract available

Keywords: APRIL (TNFSF13); BAFF - B-cell activating factor; IgA nephropathy; SGLT 2 inhibitor; biomarker; cathepsin S (Cat S); pathogenesis; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic IgA nephropathy: a nephrologist’s challenge in 2023

Similar articles

See all similar articles

References

    1. Woo KT, Chan CM, Chin YM, Choong HL, Tan HK, Foo M, et al. . Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract. (2010) 116:c337–46. doi: 10.1159/000319594 - DOI - PubMed
    1. Jarrick S, Lundberg S, Welander A, Carrero JJ, Höijer J, Bottai M, et al. . Mortality in IgA nephropathy: A nationwide population-based cohort study. J Am Soc Nephrol. (2019) 30:866–76. doi: 10.1681/asn.2018101017 - DOI - PMC - PubMed
    1. Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. (2011) 22:752. doi: 10.1681/ASN.2010040355 - DOI - PMC - PubMed
    1. Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. . Long-term outcomes in IgA nephropathy. Clin J. (2023) 18:727–38. doi: 10.2215/CJN.0000000000000135 - DOI - PMC - PubMed
    1. Barbour SJ, Reich JN. Risk stratification of patients with IgA nephropathy. Am J Kidney Dis. (2012) 59:865–73. doi: 10.1053/j.ajkd.2012.02.326 - DOI - PubMed

Publication types

LinkOut - more resources